MCRB Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Progress DFTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Reports WiderThanExpected Loss LRCX Q1 2026 Earnings EPS Surpasses Estimates by Nearly 5 Amid Challenging Environment FITBI Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations Alzamend Neuro Inc ALZN Q1 2026 Earnings NarrowerthanExpected Loss as EarlyStage Biotech Continues RD Focus EPR Properties Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain